(Total Views: 146)
Posted On: 10/12/2023 7:50:10 AM
Post# of 101
The realm of biopharmaceuticals is vast, but Bioxytran, Inc. carves a unique niche. With their focus on Glycovirology and a strong OTC presence marked by a $25.2M+ market cap, the future of virus elimination and lifespan extension seems promising.
(0)
(0)Scroll down for more posts ▼
